Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review

Autor: Besag Fmc, Vasey Mj, Wong Ick, Lao Ksj

Publikováno v: CNS Drugs. 33:1167-1186

Melatonin is widely available either on prescription for the treatment of sleep disorders or as an over-the-counter dietary supplement. Melatonin has also recently been licensed in the UK for the short-term treatment of jetlag. Little is known about

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7511fc611778b4b722be34f68d0fa03e
https://doi.org/10.1007/s40263-019-00680-w

Prevalence and disease burden of chronic cough in nine cities of China: an observational study.

Autor: Chen L; Global Medical Affairs, MRL, MSD China, Shanghai, China., Lao KSJ; Global Medical and Scientific Affairs, MSD, Hong Kong, Hong Kong Special Administration Region, China., Yi F; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Xia K; Global Medical Affairs, MRL, MSD China, Shanghai, China., Lai K; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. klai@vip.163.com.

Publikováno v: BMC pulmonary medicine [BMC Pulm Med] 2024 Jul 04; Vol. 24 (1), pp. 322. Date of Electronic Publication: 2024 Jul 04.

Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: A multi-centre, double-blind, randomised clinical trial.

Autor: Chan EW; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR.; Department of Pharmacy, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; Shenzhen Institute of Research and Innovation, The University of Hong Kong, Shenzhen, China., Lao KSJ; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR.; Global Medical Affairs, Merck Sharp & Dohme, Xuhui, Shanghai, China., Lam L; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR., Tsui SH; Accident and Emergency Department, Queen Mary Hospital, Pok Fu Lam, Hong Kong SAR., Lui CT; Accident and Emergency Department, Tuen Mun Hospital, Tuen Mun, Hong Kong SAR., Wong CP; Accident and Emergency Department, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong SAR., Graham CA; Accident and Emergency Medicine Academic Unit, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR.; Department of Emergency Medicine, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR., Cheng CH; Accident and Emergency Medicine Academic Unit, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR.; Department of Emergency Medicine, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR., Chung TS; Accident and Emergency Department, Ruttonjee Hospital, Wan Chai, Hong Kong SAR., Lam HF; Accident and Emergency Department, United Christian Hospital, Kwun Tong, Hong Kong SAR., Ting SM; Accident and Emergency Department, United Christian Hospital, Kwun Tong, Hong Kong SAR., Knott JC; Department of Critical Care, University of Melbourne, Parkville, Australia., Taylor DM; Emergency Department, Austin Hospital, Heidelberg, Victoria, Australia.; Department of Medicine, University of Melbourne, Parkville, Victoria, Australia., Kong DCM; Pharmacy Department, Ballarat Health Services, Ballarat, Victoria, Australia.; Centre for Medicine Use and Safety, Monash University, Victoria, Australia., Leung LP; Emergency Medicine Unit, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR., Wong ICK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR.; Department of Pharmacy, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; Research Department of Practice and Policy, UCL School of Pharmacy, London, United Kingdom.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2021 Feb 11; Vol. 32, pp. 100751. Date of Electronic Publication: 2021 Feb 11 (Print Publication: 2021).

Mortality Risk Associated with Haloperidol Use Compared with Other Antipsychotics: An 11-Year Population-Based Propensity-Score-Matched Cohort Study.

Autor: Lao KSJ; Department of Pharmacology and Pharmacy, Centre for Safe Medication Practice and Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Office 02-08, 2/F Laboratory Block, 21 Sassoon Road, Pokfulam, Hong Kong SAR, China.; Global Medical Affairs, Merck Research Laboratories, MSD, Shanghai, China., Wong AYS; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK., Wong ICK; Department of Pharmacology and Pharmacy, Centre for Safe Medication Practice and Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Office 02-08, 2/F Laboratory Block, 21 Sassoon Road, Pokfulam, Hong Kong SAR, China.; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK., Besag FMC; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.; East London NHS Foundation Trust, Bedfordshire, UK.; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Chang WC; Department of Psychiatry, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong SAR, China., Lee EHM; Department of Psychiatry, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Chen EYH; Department of Psychiatry, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong SAR, China., Blais JE; Department of Pharmacology and Pharmacy, Centre for Safe Medication Practice and Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Office 02-08, 2/F Laboratory Block, 21 Sassoon Road, Pokfulam, Hong Kong SAR, China., Chan EW; Department of Pharmacology and Pharmacy, Centre for Safe Medication Practice and Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Office 02-08, 2/F Laboratory Block, 21 Sassoon Road, Pokfulam, Hong Kong SAR, China. ewchan@hku.hk.

Publikováno v: CNS drugs [CNS Drugs] 2020 Feb; Vol. 34 (2), pp. 197-206.